Sun, Bao
Ma, Siqing
Xiao, Feiyan
Luo, Jianquan
Liu, Mouze
Liu, Wenhui
Luo, Zhiying
Funding for this research was provided by:
Natural Science Foundation of Hunan Province China (2017JJ3462, 2020JJ5822, 2021JJ40847, 2017JJ3462, 2020JJ5822, 2021JJ40847, 2017JJ3462, 2020JJ5822, 2021JJ40847, 2017JJ3462, 2020JJ5822, 2021JJ40847)
National Natural Scientific Foundation of China (82003883)
Article History
Received: 29 December 2022
Accepted: 25 May 2023
First Online: 31 May 2023
Declarations
:
: This study was conducted in compliance with the stipulations of the Declaration of Helsinki. This project was approved by the Ethics Committee of the Institute of Clinical Pharmacology at Central South University (CTXY-110005) and the trial was previously registered: ChiCTRONC-11001532. Written informed consent was received from participants before enrolment.
: Written informed consent for publication was obtained from all participants.
: The authors declared that no potential conflicts of interest exist.